Trajan Group Holdings Limited (TRJNF) fair value: what the stock is really worth
We calculate from audited financials what Trajan Group Holdings Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Trajan Group Holdings Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
26‑month range $0.4000 – $0.8650 · fair‑value band $0.1200 – $0.4200 · the $0.4000 price screens above the $0.2400 fair value. Dashed = 300-day average. As of Sep 13, 2026.
Trajan Group Holdings Limited develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
Show more
Trajan Group Holdings Limited develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, inlet liners, rings, and tubing products; and sampling products, comprising septa, caps, liners, well plates and sealing mats, crimping tools, and micro sampling tools, as well as automation systems and consumables. It also provides pathology products, consisting of NBF containers, adhesive and frosted microscope slides, coverslips, microtome blades, biopsy pads, microscope slide storage trays/mailers, microscope slide and cassette storage boxes, histology wax plus, and tissue marking dyes and sets, and MiPlatform, a smartphone adapter; on-line and laboratory instruments and related parts and services; and miniaturized and portable instrumentation, as well as products and services related to microsampling. In addition, the company offers analytical, automation, life sciences, sampling literature support products. The company was incorporated in 2011 and is headquartered in Ringwood, Australia.
Stock analysis
Trajan Group Holdings Limited (TRJNF) currently trades at $0.4000, while our model-based Fair Value estimate is $0.2400, implying the stock looks roughly 66.7% overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of $0.4600 per share, and 3 of the 10 models we run sit above the $0.4000 price.
Bear case: the Multiples group reads lowest at $0.1100, and 7 of the 10 models stay below the price. Evidence for this calculation is low.
Scenario range: $0.1200 (bear) to $0.4200 (bull), the price of $0.4000 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 52/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Trajan Group Holdings Limited reported revenue of A$166M in FY2025 versus A$76.6M in FY2021, a compound +21.4%/yr. Reported net income was −A$4.5M in FY2025.
Key figures
Market cap $61.0M · P/S ratio 0.36 · EPS (TTM) $−0.0100 · Dividend yield 5.5% · Net margin −2.7% · Return on equity −1.3% · Return on assets (EBIT) 1.7% · Operating margin 1.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 20% below its 52-week high, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −40%, TRJNF screens cheaper than that median.
Fair Value models
Bear $0.1200Fair Value $0.2400Bull $0.4200
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+7.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.7%
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−0.3% (2021) → 2.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Price in line with expectations
The price assumes less growth than the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+5.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+3.9%
Yearly sales growth analysts expect, extended to five years.
Compare Trajan Group Holdings Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 202 stocks
Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score52 · Below median
Fair Value upside−41% · Below median
Profitability
Return on assets1% · Below median
Net margin (TTM)−1% · Bottom 25%
Operating margin (TTM)1% · Bottom 25%
Growth and dividend
Revenue growth4% · Below median
Dividend yield (TTM)5.5% · Top 25%
Balance sheet
Debt / equity0.38× · Highest 25%
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
P/B0.58× · Cheapest 25%
P/S (TTM)0.36× · Cheapest 25%
P/FCF9.1× · Pricier than median
EV/EBITDA8.6× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 16
FUTURE (revenue growth)19· sector 24
PAST (return on equity)0· sector 25
HEALTH (low debt)81· sector 96
DIVIDEND (yield)0· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Trajan Group Holdings Limited Fair Value". https://www.fairvalue-calculator.com/stock/TRJNF
Frequently asked questions
Is Trajan Group Holdings Limited (TRJNF) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of $0.2400 versus a price of $0.4000, about −40% upside (overvalued).
What is the fair value of TRJNF?
Our model-based fair value for Trajan Group Holdings Limited is $0.2400 (as of Sep 13, 2026), built from audited fundamentals. The current price: $0.4000.
What is the quality score of TRJNF?
Trajan Group Holdings Limited has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Trajan Group Holdings Limited (TRJNF)?
Our model-based price target is the fair value of $0.2400 (as of Sep 13, 2026) from 10 valuation models. Cautious scenario $0.1200, optimistic scenario $0.4200. It is a calculation from audited fundamentals, not an analyst target.
What is the Trajan Group Holdings Limited stock forecast for 2026?
Our models put fair value at $0.2400, about −40% upside versus a price of $0.4000 (overvalued). Cautious scenario $0.1200, optimistic scenario $0.4200. The calculation is refreshed regularly with new filings.
What is the revenue of Trajan Group Holdings Limited (TRJNF)?
Trajan Group Holdings Limited reported trailing-twelve-month revenue of about $170M (latest available figure, as of Sep 13, 2026).
Does Trajan Group Holdings Limited pay a dividend?
Trajan Group Holdings Limited currently shows a dividend yield of about 5.48% relative to its recent price (as of Sep 13, 2026).
What growth is priced into Trajan Group Holdings Limited (TRJNF)?
For today's price to be fair in a discounted-cash-flow model, Trajan Group Holdings Limited would have to grow free cash flow by +5.8 % per year for five years (discount rate 11.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew +21.4 % per year. As of Sep 13, 2026.
What discount rate (WACC) does the fair value of TRJNF use?
Our models discount Trajan Group Holdings Limited at 11.3 %: a base by market capitalisation (micro), damped by beta 0.55, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Trajan Group Holdings Limited that is +5.8 % per year a year over ten years, using the same discount rate (11.3 %) and the same formula as our fair value.
How much growth has Trajan Group Holdings Limited (TRJNF) delivered so far?
Over the past 4 years revenue at Trajan Group Holdings Limited grew +21.4 % a year. The price currently implies +5.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Trajan Group Holdings Limited (TRJNF) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into Trajan Group Holdings Limited (+5.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Trajan Group Holdings Limited (TRJNF)?
The free-cash-flow yield on the price is 11.06 %: that much free cash flow Trajan Group Holdings Limited produces per unit of market value. When it exceeds the discount rate of our models (11.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Trajan Group Holdings Limited (TRJNF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Trajan Group Holdings Limited it is $0.2400 per share (as of Sep 13, 2026), against a price of $0.4000. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Trajan Group Holdings Limited stock overvalued or undervalued in 2026?
As of Sep 13, 2026, TRJNF trades above its calculated fair value: price $0.4000, fair value $0.2400, a gap of about −40% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TRJNF?
No. The price is what the market pays today ($0.4000); the fair value is what the company's own numbers justify ($0.2400). For Trajan Group Holdings Limited the two are $0.1600 per share apart. That gap is exactly why we show both numbers side by side.
How much is Trajan Group Holdings Limited worth?
The market values Trajan Group Holdings Limited at about $61.0M (market capitalisation, as of Sep 13, 2026). Per share that is $0.4000; our models calculate a fair value of $0.2400 per share.
What do the bullish and bearish scenarios say about TRJNF?
Our models span a range for Trajan Group Holdings Limited: cautious scenario $0.1200, base $0.2400, optimistic $0.4200 per share (as of Sep 13, 2026, price $0.4000). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Trajan Group Holdings Limited (TRJNF)?
Balance-sheet figures for Trajan Group Holdings Limited (as of Sep 13, 2026): return on equity −1.3%, debt of 0.38 per unit of equity. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is TRJNF from its 52-week high?
Trajan Group Holdings Limited trades at $0.4000, about 20% below its 52-week high of $0.5000 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of $0.2400 is for.
Which stocks are comparable to Trajan Group Holdings Limited?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Trajan Group Holdings Limited stock attractive at the current price?
The data as of Sep 13, 2026: price $0.4000, calculated fair value $0.2400 (−40%), Quality Score 52/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TRJNF calculated?
We run Trajan Group Holdings Limited through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.2400, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Trajan Group Holdings Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Trajan Group Holdings Limited right now?
The model range is unusually wide ($0.1200 to $0.4200). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Trajan Group Holdings Limited
How large is the market capitalisation of Trajan Group Holdings Limited (TRJNF)?
The market capitalisation of Trajan Group Holdings Limited is $61.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Trajan Group Holdings Limited (TRJNF)?
The price-to-sales ratio of Trajan Group Holdings Limited is 0.36 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Trajan Group Holdings Limited (TRJNF)?
Earnings per share at Trajan Group Holdings Limited are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Trajan Group Holdings Limited (TRJNF)?
The dividend yield of Trajan Group Holdings Limited is 5.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Trajan Group Holdings Limited (TRJNF)?
The net margin of Trajan Group Holdings Limited is −2.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Trajan Group Holdings Limited (TRJNF)?
The return on equity (ROE) of Trajan Group Holdings Limited is −1.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Trajan Group Holdings Limited (TRJNF)?
On an EBIT basis the return on assets of Trajan Group Holdings Limited is 1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Trajan Group Holdings Limited (TRJNF)?
The operating margin of Trajan Group Holdings Limited is 1.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Trajan Group Holdings Limited (TRJNF)?
Revenue at Trajan Group Holdings Limited is growing +3.8% versus a year earlier (3y avg +15.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Trajan Group Holdings Limited (TRJNF) carry?
The net debt of Trajan Group Holdings Limited is $29.5M (fiscal year 2025, ≈ 4.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Trajan Group Holdings Limited in the live analysis
One click puts Trajan Group Holdings Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 13, 2026